Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats.
Phenom today unveiled the winners of its 2025 Talent Experience awards. The awards celebrate the extraordinary achievements ...
In a report released today, Matthew Weston from UBS maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price target of ...
ShareIn commemoration of the 2025 International Women’s Day, Merck Foundation, the philanthropic arm of Merck KGaA Germany and African First Ladies have reaffirmed their commitment to empowering women ...
In a report released today, James Quigley from Goldman Sachs maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price ...
Lilongwe [Malawi]/Mumbai (Maharashtra) [India], March 11: Merck Foundation, the philanthropic arm of Merck KGaA Germany, ...
The Federal Circuit reinstated a challenge of a Merck KGaA unit’s pigment patent by South Korea-based CQV Co. on Monday, ...
Pharmaceutical Technology on MSN8d
Merck KGaA reports YE24 earnings growth amid SpringWorks acquisition talksWhile the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.
Q4 2024 Results Conference Call March 6, 2025 8:00 AM ETCompany ParticipantsFlorian Schraeder - Head of Investor ...
One of Merck KGaA’s leading immunology assets has flunked a phase 2 lupus trial. | One of Merck KGaA’s leading immunology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback